CIK 0000926617
- Non-accelerated filer
- Smaller reporting company
Aspira Women's Health Inc.
Sign in to watch- Ticker
- AWHL
- Exchange
- OTC
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330595156
- Phone
- +1 512-519-0400
- Business address
- 12117 BEE CAVES ROAD BUILDING THREE, SUITE 100, AUSTIN, TX, 78738
- Former names
- VERMILLION, INC., CIPHERGEN BIOSYSTEMS INC
- 4 Open-market buy Director bought 16,502 shares at $1.44 ($23,763)
- 4 Open-market buy President & Chief Exec Officer bought 16,502 shares at $1.44 ($23,763)
- 4 Open-market buy Director bought 66,007 shares at $1.44 ($95,050)
- 4 Option exercise 10% owner acquired 4,055,157 shares (option exercise)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Exercise or conversion Director acquired 12,500 shares (option exercise)
- 4 Open-market buy Chief Operating Officer bought 3,500 shares at $1.51 ($5,285)
- 4 Open-market buy President & Chief Exec Officer bought 27,907 shares at $1.44 ($40,186)
- 4 Open-market buy Chief Operating Officer bought 30,000 shares at an average $1.44 ($43,050)
- 4 Open-market buy President & Chief Exec Officer bought 41,615 shares at an average $1.43 ($59,429)
- 4 Open-market buy VP Finance & CAO bought 5,000 shares at $1.42 ($7,100)
- 4 Grant or award Chief Operating Officer acquired 10,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4/A Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 17 of 28 · 551 filings